Recovery of Upper Limb Paresis at Discharge After Stroke and Its Level of Use in Activities of Daily Living 3 to 6 Months Later (Post AVC-AVQ) (Post AVC-AVQ)

June 21, 2017 updated by: University Hospital, Bordeaux

Relations Between the Level Upper Limb Paresis Recovery in Output of the Hospital Unit Continued Care and Rehabilitation and Its Level of Use in Lifestyle at Three and Six Months

The aim is to reduct spontaneous use an activities of daily living of the paretic upper limb after stroke i six months after patient discharge from rehabilitation center. The level of functional recovery at rehabilitation discharge could better guide rehabilitation strategies to enhance independence and participation in daily life.

This study aims to determine, in patients after stroke, the optimal affected upper limb recovery threshold at rehabilitation discharge to predict spontaneous level of use of affected upper limb in activities of daily living, six month later.

This study is a multicentric prognostic prospective cohort study. The main prognostic variable will be the Action Arm Test (ARAT, Lyle, 1981) score at rehabilitation discharge and the predicted variable will be the Motor Activity Log - 28 (Taub et al. 1993) score at 6 months post discharge.

Study Overview

Status

Unknown

Detailed Description

Adults after stroke will be recruited at post-acute rehabilitation discharge. Three evaluation times will be undertaken: at discharge, three and six months after discharge. Evaluation battery will focus on the three level of the Functioning International Classification: affected upper limb level of strength, proprioception and level of functional recovery, hemineglect, depression, cognition status, and activity level by doing a standardised instrumental task of daily living, and level of participation questionnaire. General characteristics will be taken into account: Age, social status, laterality.

At six months, the spontaneous level of affected upper arm use in daily living will also be assessed using accelerometers.

As the main aim of the study is to build a prediction model, the study size is calculated to observe a minimal number of events by potentially predictive variable. We consider here 7.5 events by independent variable (Vittinghof and McCulloch, 2007) and eight independent variables. According to literature review, we estimated that 35% of adults included in this study would spontaneously use their affected upper arm in activities of daily living six months after discharge. According to these data and considering 10% of protocol deviations, we calculated that 192 subjects will have to be included in the study. The inclusion duration will be 30 months.

Study Type

Observational

Enrollment (Anticipated)

192

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Bordeaux, France
        • Bordeaux University Hospital
        • Contact:
        • Principal Investigator:
          • Eric SORITA, PhD
        • Sub-Investigator:
          • Patrick DEHAIL, MD, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients eligible to participate in the study will be adults who have experienced a first stroke and are about to leave the rehabilitation facility for their home. These people should have a good oral comprehension. They must not have a psychiatric history with hospitalization of more than 6 months. They must have been independent in the activities of daily life before their stroke. They must be affiliated to a social security scheme, be willing to participate in the study and not participate in another research.

Description

Inclusion Criteria:

  • Patients over 18 years old leaving the correctional institution with orientation back home
  • First stroke deficit with non-regressive clinical expression in 24 hours
  • Independent in activities of daily living and living at home and daily activities independence before the stroke. This earlier independence is confirmed by the absence of professional carers in personal care activities (yes / no)
  • Proper oral understanding as measured by score 7 in the language screening test LAST (Flamand-Roze et al, 2011)
  • No psychiatric history that led to hospitalization for more than six months
  • Patient has given its consent within the period provided after reading the briefing note
  • Patient affiliated or beneficiary of a social security scheme.

Exclusion Criteria:

  • Lack of minimum functional motor recovery in paretic upper limb allowing the patient to go put hand to his mouth and to realize do a 45 degrees abduction with the paretic upper limb.
  • Barthel Index score (BI) less than or equal to 40. It is suggested in the literature that a score less than or equal to 40 is a key score of total dependence
  • Persistent severe hemineglect (bells test score > 6).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
stroke
  • Patients over 18 years old leaving the correctional institution with orientation back home
  • First stroke deficit with non-regressive clinical expression in 24 hours
  • Independent in activities of daily living and living at home before stroke. This earlier independence is confirmed by the absence of professional carers in personal care activities
  • Proper oral understanding as measured by score 7 in the Language Screening Test (LAST) (Flamand-Roze et al, 2011)
  • No psychiatric history that led to hospitalization for more than six months
  • Written informed consent after reading the briefing note
  • Patient affiliated or beneficiary of a social security scheme.
Measuring the functional recovery of the paretic upper limb rehabilitation outing with the scale ARAT

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Motor Activity
Time Frame: Month 6
Score of Motor Activity Log scale
Month 6

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Action Arm
Time Frame: Day 0
Score of Action Research Arm Test scale
Day 0
Action Arm
Time Frame: Day 180
Score of Action Research Arm Test scale
Day 180
Cognitive abilities
Time Frame: Day 0
Score with kettle test
Day 0
Cognitive abilities
Time Frame: Day 180
Score with kettle test
Day 180
"Mesure des HAbitudes de VIE" (MHAVIE)
Time Frame: Day 0
Score of "Mesure des HAbitudes de VIE" scale (MHAVIE)
Day 0
"Mesure des HAbitudes de VIE" (MHAVIE)
Time Frame: Day 180
Score of "Mesure des HAbitudes de VIE" scale (MHAVIE)
Day 180
"Montreal Cognitive Assessment" (MoCA)
Time Frame: Day 0
Score of "Montreal Cognitive Assessment" (MoCA)
Day 0
"Montreal Cognitive Assessment" (MoCA)
Time Frame: Day 180
Score of "Montreal Cognitive Assessment" (MoCA)
Day 180
Aphasic Depression Rating (ADRS)
Time Frame: Day 0
Score of Aphasic Depression Rating Scale (ADRS)
Day 0
Aphasic Depression Rating (ADRS)
Time Frame: Day 180
Score of Aphasic Depression Rating Scale (ADRS)
Day 180
Unilateral spatial neglect (NSU) in the vicinity of extrapersonal space
Time Frame: Day 0
Score of "Bell test (test de barrage des cloches)"
Day 0
Unilateral spatial neglect (NSU) in the vicinity of extrapersonal space
Time Frame: Day 180
Score of "Bell test (test de barrage des cloches)"
Day 180

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Eric SORITA, PhD, University Hospital, Bordeaux
  • Study Chair: Paul PEREZ, MD, Unité de Soutien Méthodologique à la Recherche clinique et épidémiologique du CHU de Bordeaux

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

July 1, 2017

Primary Completion (Anticipated)

June 1, 2020

Study Completion (Anticipated)

June 1, 2020

Study Registration Dates

First Submitted

April 13, 2017

First Submitted That Met QC Criteria

April 13, 2017

First Posted (Actual)

April 18, 2017

Study Record Updates

Last Update Posted (Actual)

June 22, 2017

Last Update Submitted That Met QC Criteria

June 21, 2017

Last Verified

June 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • CHUBX2015/24

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke Rehabilitation

Clinical Trials on Scale Action Research Arm Test (ARAT)

3
Subscribe